Valproic acid stimulates proliferation and self-renewal of hematopoietic stem cells.
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Histone deacetylase inhibitors have attracted considerable attention because of their ability to overcome the differentiation block in leukemic blasts, an effect achieved either alone or in combination with differentiating agents, such as all-trans retinoic acid. We have previously reported favorable effects of the potent histone deacetylase inhibitor valproic acid in combination with all-trans retinoic acid in patients with advanced acute myeloid leukemia leading to blast cell reduction and improvement of hemoglobin. These effects were accompanied by hypergranulocytosis most likely due to an enhancement of nonleukemic myelopoiesis and the suppression of malignant hematopoiesis rather than enforced differentiation of the leukemic cells. These data prompted us to investigate the effect of valproic acid on normal hematopoietic stem cells (HSC). Here we show that valproic acid increases both proliferation and self-renewal of HSC. It accelerates cell cycle progression of HSC accompanied by a down-regulation of p21(cip-1/waf-1). Furthermore, valproic acid inhibits GSK3beta by phosphorylation on Ser9 accompanied by an activation of the Wnt signaling pathway as well as by an up-regulation of HoxB4, a target gene of Wnt signaling. Both are known to directly stimulate the proliferation of HSC and to expand the HSC pool. In summary, we here show that valproic acid, known to induce differentiation or apoptosis in leukemic blasts, stimulates the proliferation of normal HSC, an effect with a potential effect on its future role in the treatment of acute myeloid leukemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In contrast, treatment of normal hematopoietic stem cells with HDAC inhibitors has the opposite effect, maintaining self-renewal,44,48–50 possibly by preventing repression of stem cell genes by differentiation stimuli.44”
From RUNX1 regulates corepressor interactions of PU.1 (2011) · cites this paper as [49]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In contrast, in normal HSC which do not express high levels of lineage-specifying TF, DNMT1 depletion prevents stem cell gene repression by differentiation stimuli, thereby maintaining stem cell phenotype (6–15).”
From CpG methylation patterns and decitabine treatment response in acute myeloid leukemia cells and normal hematopoietic precursors (2012) · cites this paper as [7]
Experimental — accuracy not yet measuredIn the citing paper
“The DNA hypomethylating drug decitabine maintains normal hematopoietic stem cell (HSC) self-renewal but induces terminal differentiation in acute myeloid leukemia (AML) cells.”
From CpG methylation patterns and decitabine treatment response in acute myeloid leukemia cells and normal hematopoietic precursors (2012) · cites this paper as [7]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A role for Wnt signalling in self-renewal of haematopoietic stem cells
Reya, T., Duncan, A. W., Ailles, L., Domen, J., Scherer, D. C., Willert, K., Hintz, L., Nusse, R., & Weissman, I. L. (2003) · Nature · doi:10.1038/nature01593 · Cited by 2,159 · cited 3×
“The activation of the Wnt signaling pathway on valproic acid is confirmed also by the fact that HoxB4 , a target gene of the Wnt signaling pathway in HSC (14), is upregulated on exposure to valproic acid.”
BackgroundInfluentialGSK-3: tricks of the trade for a multi-tasking kinase
Doble, B. W., & Woodgett, J. R. (2003) · Journal of Cell Science · doi:10.1242/jcs.00384 · Cited by 2,084 · cited 7×
“E, influence of valproic acid (150 Ag/mL) on the activation of Akt and on the expression level of h-catenin in Sca + /lin À HSC at day 7 of culture in semisolid medium; h-tubulin: loading control.”
BackgroundInfluentialValproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells
Gottlicher, M. (2001) · The EMBO Journal · doi:10.1093/emboj/20.24.6969 · Cited by 1,887
Histone Deacetylase Is a Target of Valproic Acid-Mediated Cellular Differentiation
Gurvich, N., Tsygankova, O. M., Meinkoth, J. L., & Klein, P. S. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-0799 · Cited by 459
Plakoglobin and β-catenin: Protein interactions, regulation and biological roles
Zhurinsky, J., Shtutman, M., & Ben-Ze′ev, A. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.18.3127 · Cited by 348
Valproate Induces Replication-independent Active DNA Demethylation
Detich, N., Bovenzi, V., & Szyf, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303740200 · Cited by 345 · cited 1×
“HSC by (a) a ‘‘transcriptional reprogramming’’ of these cells through its capacity to induce histone acetylation as well as DNA demethylation in a dose-dependent manner (18), or (b) by the inhibition of GSK3h.”
BackgroundSu, Y., Ryder, J., Li, B., Wu, X., Fox, N., Solenberg, P., Brune, K., Paul, S., Zhou, Y., Liu, F., et al. (2004) · Biochemistry · doi:10.1021/bi035627j · Cited by 296
Rowe, J. M., Neuberg, D., Friedenberg, W., Bennett, J. M., Paietta, E., Makary, A. Z., Liesveld, J. L., Abboud, C. N., Dewald, G., Hayes, F. A., et al. (2004) · Blood · doi:10.1182/blood-2003-05-1686 · Cited by 277
Kuendgen, A., Strupp, C., Aivado, M., Bernhardt, A., Hildebrandt, B., Haas, R., Germing, U., & Gattermann, N. (2004) · Blood · doi:10.1182/blood-2003-12-4333 · Cited by 255
The role of retinoids and retinoic acid receptors in normal hematopoiesis
Collins, S. (2002) · Leukemia · doi:10.1038/sj.leu.2402718 · Cited by 167
Research works printed but not linked: 1
- Bug G, Romanski A, Guel H, Hoelzer D, Ottmann OG, Ruthardt M. CG1521 and CG1255: two new histone- deacetylase inhibitors for the differentiation therapy of acute myeloid leukemia. Blood 2002;100:2122a.
Cited by
Histone Deacetylase Inhibitors as Anticancer Drugs
Eckschlager, T., Plch, J., Stiborova, M., & Hrabeta, J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071414 · Cited by 1,206
“GSK3 β in vitro hematopoetic stem cells VPA [104]”
BackgroundRetinoic acid receptors: From molecular mechanisms to cancer therapy
di Masi, A., Leboffe, L., De Marinis, E., Pagano, F., Cicconi, L., Rochette-Egly, C., Lo-Coco, F., Ascenzi, P., & Nervi, C. (2015) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2014.12.003 · Cited by 403
Signaling pathways governing stem-cell fate
Blank, U., Karlsson, G., & Karlsson, S. (2008) · Blood · doi:10.1182/blood-2007-07-075168 · Cited by 355
Verhelle, D., Corral, L. G., Wong, K., Mueller, J. H., Moutouh-de Parseval, L., Jensen-Pergakes, K., Schafer, P. H., Chen, R., Glezer, E., Ferguson, G. D., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2317 · Cited by 234
“VPA, a drug that belongs to the HDAC inhibitor family, possesses antitumoral activities correlated with p21WAF-1 upregulation (29–31) and stimulates proliferation and self-renewal of HSCs (32).”
BackgroundInfluentialThe ups and downs of Wnt signaling in prevalent neurological disorders
De Ferrari, G. V., & Moon, R. T. (2006) · Oncogene · doi:10.1038/sj.onc.1210064 · Cited by 222
“Interestingly, valproic acid has been shown to activate Wnt-dependent gene expression by a complex mechanism involving inhibition of GSK3b and histone deacetylase (HDAC) activities (Chen et al., 1999; Phiel et al., 2001; Hall et al., 2002; Bug et al., 2005).”
Background
Metadata
- Authors
- Bug, G., Gül, H., Schwarz, K., Pfeifer, H., Kampfmann, M., Zheng, X., Beissert, T., Boehrer, S., Hoelzer, D., Ottmann, O. G., & Ruthardt, M.
- Affiliations
- Goethe University Frankfurt (DE)
- Medizinische Klinik II/Abteilung Hämatologie, Klinikum der Johann Wolfgang Goethe-Universität, Frankfurt, Germany
- Venue
- Cancer Research
- Published
- 2005-04-01
- Volume
- 65
- Issue
- 7
- Pages
- 2537-2541
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2100476572
- Cited by
- 195
- References
- 17
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 5 · 2023: 6 · 2022: 6 · 2021: 4 · 2020: 3 · 2019: 6 · 2018: 7 · 2017: 11 · 2016: 4 · 2015: 13 · 2014: 10 · 2013: 7 · 2012: 21
- FWCI
- 8.57
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- ORCA Online Research @Cardiff (Cardiff University) (submittedVersion)
- Funders
- Deutsche Forschungsgemeinschaft
- Topics
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Keywords
- valproic acid, hematopoietic stem cells, stem cell self-renewal, stem cell proliferation, histone deacetylase inhibitors, acute myeloid leukemia, Wnt signaling, GSK3β, HOXB4, p21, cell cycle progression, all-trans retinoic acid
- MeSH terms
- Glycogen Synthase Kinase 3 beta, Animals, Cell Cycle, Cell Differentiation, Enzyme Activation, Hematopoietic Stem Cells, Humans, Mice, Inbred C57BL, Transcription Factors, Tretinoin, Valproic Acid, Signal Transduction, Down-Regulation, Up-Regulation, Homeodomain Proteins, Cell Cycle Proteins, Antigens, CD34, Glycogen Synthase Kinase 3, Cell Proliferation, Cyclin-Dependent Kinase Inhibitor p21, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Valproic acid stimulates proliferation and self-renewal of hematopoietic stem cells. https://app.cochat.ai/papers/10.1158/0008-5472.can-04-3011
- The paper
- Bug, G., Gül, H., Schwarz, K., Pfeifer, H., Kampfmann, M., Zheng, X., Beissert, T., Boehrer, S., Hoelzer, D., Ottmann, O. G., & Ruthardt, M. (2005). Valproic acid stimulates proliferation and self-renewal of hematopoietic stem cells. Cancer Research. https://doi.org/10.1158/0008-5472.can-04-3011
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.